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was evaluated in terms of changes in the level of the main stable metabolites of nitric oxide (NO2 and NO3), in the mem-
branes of red blood cells in the blood plasma and in exhaled breath condensate (EBC). All the patiens underwent spirometry 
as well. The evaluation of the drug effectiveness was carried out before and after the treatment. 
Results. It has been established that during the period of asthma exacerbation, high levels of nitric oxide in the blood, 
red blood cells and EAC can be found, which is the sign of endothelial dysfunction. Interdependency between the indicators 
of respiratory function (degree of obstruction) and the content of nitric oxide in the SSC has been found: the more severe 
the obstruction, the higher the rates of nitrogen oxide in the SSC. The results show the positive effect of L-arginine on en-
dothelial system performance and spirometry along with a basic therapy. 
Conclusions. The use of L-arginine has a positive effect on the endothelial system and spirometry in patients with 
asthma against pathogenic therapy. 
Key words: Asthma, L-arginine, SSC, endothelial dysfunction. 
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Abstract. Pro197Leu polymorphism of the gene 
GPX1 in 102 patients with arterial hypertension and 
concomitant abdominal obesity and 97 healthy individuals 
have been studied. Disorders of distribution of genotype 
frequencies comparing with the control group at the ex-
pense of the reduction of Pro/Pro genotype frequency have 
been found in the main group. Analyzing the data, the in-
creasing risk of disorders in the GPX 1 activity in patients 
with Pro/Leu and Leu/Leu variants of polymorphism 
comparing with homozygotes for the "wild" allele at 4,7 
and 6,9 times respectively, had been revealed. Analyzing 
the changes of carbohydrate metabolism depending on the 
Pro197Leu polymorphism of the gene GPX1, it was estab-
lished that in patients with Leu/Leu genotype the produc-
tion of immunoreactive insulin, leptin, C-peptide, HOMA-
IR increased significantly. Thus, Pro-allele possesses pro-
tective properties as to the reduction in the activity of 
glutathione peroxidase. Insulin and leptin resistance de-
velop in the carriers of Leu-allele, wich causes disturbances 
in carbohydrate metabolism. 
Key words: Pro197Leu polymorphism of the gene 
GPX1, carbohydrate metabolism, insulin resistance, 
abdominal obesity, metabolic syndrome. 
Introduction. Cytoplasmic glutathione 
peroxidase (GPX 1) is one of the selenoenzymes 
important for the organism functioning, present in all 
tissues of the human body, which takes part in 
detoxication of hydrogen peroxide and products of 
lipid peroxidation, as it catalyzes the interaction of 
reduced glutathione with these substances [3, 8, 5, 
10]. Numerous pathologic processes in the organism 
are known to develop as a result of disorders in the 
mechanisms of antioxidant protection. In particular, 
the patients with insulin resistance, accompanied by 
hyperglycemia and increased production of cytokines, 
aquired oxidant stress. The accumulation of free 
radicals activates factors of transcription such as 
NFkB, which initiate the process of proinflammatory 
cytokines release[6]. The accumulation of free 
radicals results in lipid peroxidation of cellular 
membranes, causes atherosclerosis and endothelial 
dysfunction [11]. We studied single nucleotide 
polymorphism of the gene GPX 1 for going into the 
question of the dependence of these processes upon 
the disorders of redox homeostasis. The human gene 
GPX 1 is localized in 3p21 chromosome and consists 
of two exons. Several single nucleotide polymorphism 
variants of this gene have been known, but the 
Pro197Leu polymorphism has been under our study, 
at which in the position 593 the amino acid cysteine 
(C) is replaced with thymine (T) (C593T), resulting in 
substitution of the amino acid proline for leucine in 
the 197 codon. This mutation refers to missens - 
functional polymorphisms [1]. Pro-allele is «wild», 
while Leu- is a «mutant» allele. The presence of Leu-
allele causes depression of GPX 1 sensibility to 
stimulating factors [7]. 
Thus, Bastaki et al. discovered that GPX 1 
activity 6 times slows down in homozygous patients 
for the Leu-allele[3]. Zelkova T.V. et al. found out 
that the homozygous for mutant allele more often 
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suffered from coronary artery disease and 
myocardial infarction at the age before 50 [12]. 
The aim of the study. To investigate the 
dependence of carbohydrate metabolism in patients 
with arterial hypertension and concomitant 
abdominal obesity depending on Pro197Leu 
polymorphism of the GPX1gene. 
Material and methods. Pro197Leu 
polymorphism of the gene GPX1 have been studied 
in 102 patients and 97 healthy individuals by 
isolating genomic DNA from peripheral blood leuko-
cytes, after that amplification of the polymorphic 
area in the state of polymerase chain reaction (PCR) 
was performed on the programmed PCR thermal 
cyclers «Amply-4L» («Biocom», Moscow) at 
individual temperature response. Reagents "DNA-
sorb-В" option 100 were used for DNA isolation 
from lymphocytes according to instructions. PCR 
samples were prepared by means of the set 
«АмплиСенс-200-1» (Russia). Products of PCR 
were separated using electrophoresis in 3% agarose 
gel in the presence of tetraborate buffer, concentrated 
with ethidium bromide. Fragments were visualized 
by transiluminator in the presence of a marker of 
molecular mass 100-1000 bq (FermentasR », USA). 
Pearson's X2 criterion was used to estimate the 
correspondence of the genotype frequencies under 
study to theoretically expected distribution at Hardy-
Weinberg’s equation. Odds ratio (OR) with 
determination of 95 % confidence interval (CI) was 
calculated with the aim to establish the association of 
polymorphic variant of the gene with a pathological 
phenotype.  
To evaluate the dependence of carbohydrate 
metabolism depending on Pro/Leu polymorphism of 
the gene GPX1 we divided the patients into groups 
in the following way: 18 patients with Pro/Pro, 59 
with Pro/Leu and 25 with Leu/Leu genotypes, the 
control group consisted of 20 healthy individuals. 
Disorders of carbohydrate metabolism were 
diagnosed according to WHO criteria (1999). Fasting 
immunoreactive insulin (IRI), C-peptide were deter-
mined by immunoassay method, glucose content by 
glucose oxidase method, the content of glycated 
hemoglobin (HbA1C) was studied by the method of 
microcolumn chromatography to evaluate the com-
pensation of carbohydrate metabolism. 
To assess the degree of insulin resistance there 
was used small model of homeostasis (Homeostasis 
model assessment – HOMA [Matthew DR, 1985]. 
Statistical analysis of the data was carried out 
using the Student’s t-test and Pearson's rank 
correlation coefficient using the software package 
Statistica 6.0 for Windows. The difference was 
considered reliable at p<0,05. 
Results and discussion.When assessing the 
distribution of genotype frequencies of the gene 
GPX1, it has been found that in the group of patients 
with abdominal obesity against the background of 
arterial hypertension there takes place a significant 
reduction of the frequency of Pro/Pro genotype as 
compared with the control group (X2=7,0, p<0,05 ), 
while there hasn’t been found out a reliable 
difference between the frequencies of Pro/
LeuandLeu/Leu genotypes in the main and control 
groups (X2=1,9, p>0,05 and X2=2,6, p>0,05 ). 
It has been revealed that Pro/Leu and Leu/Leu 
variants of polymorphism are associated with 
increased risk of violation of redox system in 
patients with metabolic syndrome compared with a 
group of healthy subjects (table 1). Thus, it has been 
found out that in patients with Pro/Leu 
polymorphism the risk of disturbance of GPX1 
activity increases 5,2 times (p<0,05, OR=1,65, 
CI=0,95 % 0,94-2,90; table 1 ), and in patients with 
Leu/Leu genotype the risk of such patology is 6,0 
times higher than in persons with Pro/Pro genotype 
(P<0,05, OR=1,92, CI 0,95 %=0,93-3,97; table 1 ). 
So, the risk of reduction of GPX 1 activity in a 
dose- dependent way is associated with the presence 
of «mutant» Leu-allele, while homozygous for the 
«wild» Pro-allele had significantly lower risk of this 
disturbance development. Proallele has protective 
qualities concerning the development of redox sys-
tem violation.  
When studying the dependence of indices of 
carbohydrate metabolism onPro197Leu poly-
morphism of GPX1 gene, a significantly higher level 
of IRI in homozygousgroup for the mutant allele in 
relation to the heterozygous group for this allele and 
homozygous ones for wild allele has been received, 
62,8 % and 37,8 % higher respectively (p<0,05) 
(table 2). A credible growth of IRI in patients with 
Pro/Pro, Pro/Leu and Leu/Leu genotypes in relation 
Table 1 
The distribution of genotype frequencies depending on GPX Pro197Leu polymorphism gene 1  
in patients with hypertension and concomitant abdominal obesity and the control group 
Genotypes 
Cases Controls 
Х2 р OR 0,95% CI 
102 97 
Genotype frequency Pro/ 




Leu 0,578 0,454 1,65 0,94-2,90 
Genotype frequency 
Leu /Leu 0,245 0,144 1,92 0,93-3,97 
Note. X2 - Pearson criterion, OR - odds ratio, CI - confidence interval 
Буковинський медичний вісник        Том 17, № 4 (68), 2013 
8 
 
Notes. 1. n - number of observations; 2. * - the probability of changes in relation to control; 3. **- the probability of changes in 
relation to the group with Pro / Leu-genotype; 4. ***- chance changes in relation to group with Leu / Leu genotype 
Index 
GenotypesGPX 1 , n=102 Control group, 
n=20 Pro/ Pro Pro/ Leu Leu/ Leu 






*/*** 25,69±2,108* 6,11±1,314 
HOMA-IR 4,35±0,124*/*** 4,187±0,183*/*** 8,97±0,367* 0,97±0,035 
C-peptide, ng/ml 3,98±0,183 */**/*** 5,23±0,149* 5,72±0,218* 1,286±0,124 
Leptin, ng / ml 16,22±4,106*/*** 20,22±3,768* 30,28±4,357* 4,72±0,153 
HbA1C, % 6,55±0,326* 7,69±0,085* 8,23±0,962* 4,42±0,577 
Table 2 
Peculiarities of indicators of carbohydrate metabolism and anthropometric features in hypertensive  
patients with concomitant abdominal obesity according to Pro197Leu polymorphism of the gene GPX 1 
to the group of healthy individuals was found 2,6, 
3,1 and 4,2 times higher. The content of leptin was 
significantly 1,9 times higher in the group with Leu/
Leu genotype compared with the group whith Pro/
Pro genotype and corresponding 3,4, 4,3 and 6,4 
times higher in the groups with Pro/Pro, Pro/Leu and 
Leu/Leu genotypes in relation to the control group 
(p<0,05). 
The level of C-peptide in the groups with Pro/
Leu and Leu/Leu genotypes was significantly 28,9 % 
and 43,8 % higher than the value of this indicator in 
the group with Pro/Pro genotype. The level of C-
peptide in all groups of the main group, namely in 
Pro/Pro, Pro/Leu and Leu/Leu patients compared 
with the control group was 3,1, 3,9 and 4,5 times 
higher respectively. 
A significant rise in glucose level in all patients 
of the main group compared with the control one, 
namely in the groups with Pro/Pro, Pro/Leu and Leu/
Leu genotypes was established to be 33,5 %, 58,4 % 
and 73,5 % higher correspondingly without credible 
intergroup differences (p<0,05). 
A significantly higher value of HOMA-IR has 
been obtained in the group of patients homozygous 
for the mutant allele compared with groups with Pro/
Leu and Leu/Leu genotypes 2,1 and 2,2 times 
respectively. HOMA-IR value was credibly 4,5, 4,3 
and 9,3 times higher in patients with Pro/Pro, Pro/
Leu and Leu/Leu genotypes compared with the 
control group respectively. 
The level of HbA1c was significantly 1,5, 1,8 
and 1,9 times higher in patients with Pro/Pro, Pro/
Leu and Leu/Leu genotypes in the main group in 
relation to the control group respectively (p<0,05). 
There wasn’t any reliable group difference depend-
ing on Pro/Leu polymorphism of GPX1. 
These results coincide with the data by Hironori 
Kobayashi and co-authors, who revealed GPX1 in 
adipocytes and described the reduction in activity of 
this enzyme in hypertrophied adipocytes of patients 
with type 2 diabetes. The authors believe that against 
the background of the free radical processes 
activation in adipocytes in patients with diabetes 
mellitus type 2 and as a result of reduced GPX1 
production, inhibition of phosphorylation of insulin 
receptors with subsequent development of insulin 
resistance develops [9]. 
Conclusions 
1. In patients with arterial hypertension against 
the background of abdominal obesity the risk of 
reduction of glutathione peroxidase1 activity is 
associated in a dose-dependent manner with the 
presence of «mutant» Leu-allele, while homozygous 
for the «wild» Pro-allele had a significantly lower 
risk of this disorder. 
2. The presence of Leu-allele in genotype of 
patients with arterial hypertension against the back-
ground of abdominal obesity is connected with the 
disorder of carbohydrate metabolism as a result of 
insulin and leptin resistance development. 
Prospects for further research. The survey 
results indicate the necessity of development of 
effective measures for carbohydrate metabolism 
correction in hypertensive patients against the back-
ground of abdominal obesity. 
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ОСОБЕННОСТИ УГЛЕВОДНОГО ОБМЕНА У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ  
ГИПЕРТЕНЗИЕЙ НА ФОНЕ АБДОМИНАЛЬНОГО ОЖИРЕНИЯ В ЗАВИСИМОСТИ  
ОТ PRO197LEU ПОЛИМОРФИЗМА ГЕНА GPX 1 
Н.О. Абрамова, Н.В. Пашковская 
Резюме. Нами исследовано Pro197Leu полиморфизм гена GPX1 у 102 больных с артериальной гипертензией и 
сопутствующим абдоминальным ожирением и 97 практически здоровых лиц. В основной группе выявлено наруше-
ние распределения частот генотипов по сравнению с группой контроля за счет снижения частоты Pro/Pro генотипа. 
При анализе полученных данных мы обнаружили рост риска нарушения активности GPX1 у лиц с Pro/Leu и Leu/
Leu вариантами полиморфизма по сравнению с гомозиготами по «дикому» аллелю в 4,7 и 6,9 раза соответственно. 
При анализе изменений углеводного обмена в зависимости от полиморфизма Pro197Leu гена GPX1, мы установи-
ли, что у лиц с Leu/Leu генотипом достоверно возрастала продукция имунореактиного инсулина, лептина, С-
пептида и соответственно повышался HOMA - IR. Итак, Pro-аллель обладает протекторными свойствами по сниже-
нию активности глутатионпероксидазы. У носителей Leu-аллеля развивается инсулино- и лептинорезистентнисть, 
что приводит к возникновению нарушений углеводного обмена. 
Ключевые слова: Pro197Leu полиморфизм гена GPX1, углеводный обмен, инсулинорезистентность, абдоми-
нальное ожирение, метаболический синдром. 
ОСОБЛИВОСТІ ВУГЛЕВОДНОГО ОБМІНУ У ПАЦІЄНТІВ ІЗ АРТЕРІАЛЬНОЮ  
ГІПЕРТЕНЗІЄЮ НА ТЛІ АБДОМІНАЛЬНОГО ОЖИРІННЯ ЗАЛЕЖНО ВІД  
PRO197LEU ПОЛІМОРФІЗМУ ГЕНА GPX 1 
Н.О. Абрамова, Н.В. Пашковська 
Резюме. Нами досліджено Pro197Leu поліморфізм гена GPX1 у 102 хворих на артеріальну гіпертензію із супу-
тнім абдомінальним ожирінням та 97 практично здорових осіб. В основній групі виявлено порушення розподілу 
частот генотипів порівняно із групою контролю за рахунок зниження частоти Pro/Pro генотипу. При аналізі отрима-
них даних ми виявили зростання ризику порушення активності GPX 1 у осіб із Pro/Leu та Leu /Leu варіантами полі-
морфізму порівняно із гомозиготами за «диким» алелем у 4,7 та 6,9 раза. Під час аналізу змін вуглеводного обміну 
залежно від поліморфізму Pro197Leu гена GPX1, ми встановили, що в осіб із Leu /Leu генотипом вірогідно зростала 
продукція імунореактиного інсуліну, лептину, С-пептиду та відповідно підвищувався HOMA-IR. Отже, Pro-алель 
володіє протекторними властивостями щодо зниження активності глутатіонпероксидази. У носіїв Leu-алеля розви-
вається інсуліно- та лептинорезистентність, що призводить до виникнення порушень вуглеводного обміну. 
Ключові слова: Pro197Leu поліморфізм гена GPX1, вуглеводний обмін, інсулінорезистентність, абдомінальне 
ожиріння, метаболічний синдром. 
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